The human body contains systems that are filled with neuromodulators (receptors) and these sophisticated receptors help regulate a variety of physiological processes including movement, mood, memory, appetite and pain. In much the same manner that the human body’s endocrine system receptors respond to opiates – the root compounds of many pain relieving medications like morphine, codeine and hydrocodone (Vicodin) – the body’s endocannabinoid system receptors respond to the compounds present in cannabis called cannabinoids.
Research shows cannabis to be an effective therapy for MS patients because it not only treats many of the symptoms, but studies show that multiple cannabinoids slow the neurodegenerative processes that lead to disability. There is a reason that MS is on the list of qualifying, debilitating medical conditions in most of the US that have a medical marijuana program. Several of the cannabinoids found in cannabis have been shown to directly help with muscle spasms, tremors, fatigue and depression.
Tetrahydrocannabinol (THC) is the psychoactive cannabinoid known to produce the euphoric feeling of being “high.” It also demonstrates impressive medical efficacy in the treatment of MS. THC is a strong pain reliever and anti-inflammatory. It also relieves nausea, stimulates the appetite, and can help battle depression. Most impressively, it is one of cannabinoids which act as a neuroprotectant.
Cannabidiol (CBD) has been shown to reduce inflammation, relieve pain, and provide clear-headed and stress-relieving calming effects. Most importantly, CBD reduces the severity and frequency of MS spasms, as does tetrahydrocannabivarin (THCV). Cannabinol (CBN) is a strong sedative cannabinoid that acts as a sleep aid without the negative side effects associated with pharmaceutical counterparts.